iKnowMed Content Updates Copied

10/27/20262026 ContentContent releasePhysician, Clinical, Admin, Billing

Oct. 27, 2026

The Filgrastim Therapeutic Interchange Management content group was updated to include Filgrastim-laha Subcutaneous (Filkri).

Oct. 8, 2026

The Pegfilgrastim Therapeutic Interchange Management content group was updated.

The following new 505(b)(2) Therapeutic Interchange groups are available for use by beta sites only at this time:

  • Docetaxel 505(b)(2)
  • Pemetrexed 505(b)(2)

Sept. 2, 2026

Intravenous Iron was added to the Therapeutic Interchange Management content group.

Aug. 31, 2026

Immunoglobulin (IVIG) was added to the Therapeutic Interchange Management content group.

Aug. 6, 2026

Nereus (Tradipitant Oral) was removed from the Fosaprepitant (NK-1 Antiemetics) Therapeutic Interchange Management content group.

July 20, 2026

The following updates were made to existing Therapeutic Interchange Management content groups:

  • Denosumab (Prolia) has been updated to include denosumab-desu Subcutaneous (60 mg/mL – Osvyrti)
  • Denosumab (Xgeva) has been updated to include denosumab-desu Subcutaneous (120 mg/1.7 mL – Jubereq)

June 5, 2026

Fosaprepitant (NK-1 Antiemetics) was added to the Therapeutic Interchange Management content groups.